T-Cell and NK-Cell Neoplasm — Trials

T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 351–400 of 566 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02341209	Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma(CTCL)	terminated	Phase 2	1	Rochester General HospitalOTHER	1	Apr 27, 2021	clinicaltrials
NCT03292406	A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)(CTCL)	completed	Phase 2	86	Galderma R&DINDUSTRY	3	Apr 8, 2021